Aldawaa net profit up 8% to SAR 329.2M in 2023, Q4 at SAR 92.4M

Aldawaa net profit up 8% to SAR 329.2M in 2023, Q4 at SAR 92.4M

18/03/2024 Argaam Exclusive

View other reports

Aldawaa Medical Services Co. reported a net profit of SAR 329.2 million for 2023, an increase of 8% from SAR 305.4 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 5,372.24 5,741.36 6.9 %
Gross Income 2,019.60 2,106.62 4.3 %
Operating Income 374.35 479.39 28.1 %
Net Income 305.45 329.22 7.8 %
Average Shares 85.00 85.00 -
EPS (Riyals) 3.59 3.87 7.8 %

This was propelled by the company’s positive sales momentum, which led to a year-on-year (YoY) rise of 4.3%, or SAR 87 million, in gross profit, in addition to its effective asset management and cost control. It also cited a 24.2% YoY hike in operating profit.

 

Q4 2023 net profit rose 3% YoY to SAR 92.4 million, from SAR 89.51 million in the prior-year period.

 

On a quarterly basis, net profit grew 29.6% from SAR 71.28 million.



Current Quarter Comparison (M)

Compared With The
Item Q4 2022 Q4 2023 Change‬
Revenues 1,458.30 1,458.09 0.0 %
Gross Income 533.69 525.09 (1.6 %)
Operating Income 130.39 140.39 7.7 %
Net Income 89.51 92.35 3.2 %
Average Shares 85.00 85.00 -
EPS (Riyals) 1.05 1.09 3.2 %

Total shareholders’ equity, no minority interest, stood at SAR 1.31 billion by Dec. 31, 2023, compared to SAR 1.09 billion a year earlier.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 1,176.38 - 446.33 - 91.48 -
Q2 2020 1,303.84 - 530.76 - 131.66 -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 1,209.72 2.8 % 451.96 1.3 % 74.35 (18.7 %)
Q2 2021 1,266.77 (2.8 %) 457.98 (13.7 %) 66.91 (49.2 %)
Q3 2021 1,259.56 - 451.39 - 50.81 -
Q4 2021 1,298.34 - 533.08 - 75.82 -
Q1 2022 1,294.82 7.0 % 494.18 9.3 % 70.71 (4.9 %)
Q2 2022 1,310.19 3.4 % 506.79 10.7 % 90.55 35.3 %
Q3 2022 1,308.93 3.9 % 484.94 7.4 % 82.69 62.7 %
Q4 2022 1,458.30 12.3 % 533.69 0.1 % 130.39 72.0 %
Q1 2023 1,407.59 8.7 % 534.98 8.3 % 116.00 64.0 %
Q2 2023 1,436.74 9.7 % 525.64 3.7 % 126.28 39.5 %
Q3 2023 1,438.95 9.9 % 520.91 7.4 % 104.60 26.5 %
Q4 2023 1,458.09 0.0 % 525.09 (1.6 %) 140.39 7.7 %
2023 5,741.36 6.9 % 2,106.62 4.3 % 479.39 28.1 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 23.11 - 0.29 (52.93) 76.04 0.95
Q2 2020 55.35 - 0.69 (61.91) 117.26 1.47
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 78.84 241.2 % 0.99 21.49 57.35 0.72
Q2 2021 52.94 (4.4 %) 0.62 5.84 47.10 0.55
Q3 2021 38.29 - 0.45 9.85 28.44 0.33
Q4 2021 69.08 - 0.81 26.24 42.84 0.50
Q1 2022 87.11 10.5 % 1.02 38.14 48.97 0.58
Q2 2022 80.67 52.4 % 0.95 14.47 66.21 0.78
Q3 2022 48.15 25.7 % 0.57 (1.08) 49.24 0.58
Q4 2022 89.51 29.6 % 1.05 7.74 81.77 0.96
Q1 2023 76.25 (12.5 %) 0.90 - 76.25 0.90
Q2 2023 89.33 10.7 % 1.05 - 89.33 1.05
Q3 2023 71.28 48.0 % 0.84 - 71.28 0.84
Q4 2023 92.35 3.2 % 1.09 - 92.35 1.09
2023 329.22 7.8 % 3.87 - 329.22 3.87

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 37.63 % 11.95 % 3.49 %
Q1 2022 37.83 % 12.05 % 3.27 %
Q2 2022 38.46 % 12.59 % 3.61 %
Q3 2022 38.74 % 13.20 % 3.98 %
Q4 2022 37.59 % 13.57 % 4.58 %
Q1 2023 37.56 % 13.96 % 4.99 %
Q2 2023 37.05 % 14.35 % 5.29 %
Q3 2023 36.84 % 14.47 % 5.55 %
Q4 2023 36.69 % 14.82 % 5.73 %
2023 36.69 % 14.69 % 5.73 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 79.85 - - -
Q2 2020 79.85 - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 79.85 - - 14.62
Q2 2021 85.00 - - 14.74
Q3 2021 85.00 - - 12.46
Q4 2021 85.00 2.81 2.07 11.64
Q1 2022 85.00 2.91 1.97 12.61
Q2 2022 85.00 3.24 2.19 12.78
Q3 2022 85.00 3.35 2.44 12.07
Q4 2022 85.00 3.59 2.90 12.88
Q1 2023 85.00 3.47 3.22 12.67
Q2 2023 85.00 3.57 3.49 14.74
Q3 2023 85.00 3.84 3.75 14.17
Q4 2023 85.00 3.87 3.87 15.45

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 25.59 37.84 5.91
Q2 2022 20.70 30.54 5.24
Q3 2022 23.77 32.69 6.61
Q4 2022 20.01 24.83 5.58
Q1 2023 23.08 24.87 6.31
Q2 2023 27.61 28.23 6.68
Q3 2023 24.77 25.37 6.71
Q4 2023 27.32 27.32 6.85

Business Segments (Million)

Compared With The
Period Retail Sales Wholesale Logistic Services
Q1 2021 1,169.76 39.96 -
Q2 2021 1,234.85 31.92 -
Q3 2021 1,224.38 35.18 -
Q4 2021 1,257.00 41.34 -
Q1 2022 1,260.57 34.25 -
Q2 2022 1,268.35 41.84 -
Q3 2022 1,261.85 47.08 -
Q4 2022 1,376.54 81.76 -
Q1 2023 1,341.18 66.41 -
Q2 2023 1,366.98 69.76 -
Q3 2023 1,352.17 86.77 -
Q4 2023 1,382.63 58.37 17.09

Analysts Estimates (Million)

Item Q4 2023 (e) Q4 2023 (a) Change‬
Average 95.85 92.35 (3.7 %)

Estimates vs Actual (Million)

Item Q4 2023 (e) Q4 2023 (a) Change
Riyad Capital 94.00 92.35 (1.8) %
SNB Capital 97.70 92.35 (5.5) %

Current
Market Cap (M Riyal) 6,808.50
Enterprise Value (EV) (M) 7,366.97
Shares Outstanding ((M)) 85.00
EPS ( Riyal) (TTM) 4.22
Book Value (BV) ( Riyal) 16.65
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 18.98
P/E (TTM) 18.98
Price/book 4.81
Return on Average Assets (%) (TTM) 7.5
Return on Average Equity (%) (TTM) 27.4

Share Price

Aldawaa Medical Services Co. (ALDAWAA)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.